rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2008-6-23
|
pubmed:abstractText |
For patients with Stage II breast cancer with one to three positive lymph nodes, controversy exists about whether radiation as a component of treatment provides a survival benefit.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0360-3016
|
pubmed:author |
pubmed-author:BuchholzThomas ATA,
pubmed-author:DuanZhigangZ,
pubmed-author:FangShenyingS,
pubmed-author:GiordanoSharon HSH,
pubmed-author:HortobagyiGabriel NGN,
pubmed-author:HuntKelly KKK,
pubmed-author:Meric-BernstamFundaF,
pubmed-author:OhJulia LJL,
pubmed-author:PerkinsGeorge HGH,
pubmed-author:StromEric AEA,
pubmed-author:TereffeWelelaW,
pubmed-author:WoodwardWendy AWA,
pubmed-author:YuTse-KuanTK
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1022-7
|
pubmed:meshHeading |
pubmed-meshheading:18234447-Adult,
pubmed-meshheading:18234447-Aged,
pubmed-meshheading:18234447-Aged, 80 and over,
pubmed-meshheading:18234447-Axilla,
pubmed-meshheading:18234447-Breast Neoplasms,
pubmed-meshheading:18234447-Cohort Studies,
pubmed-meshheading:18234447-Female,
pubmed-meshheading:18234447-Humans,
pubmed-meshheading:18234447-Lymph Nodes,
pubmed-meshheading:18234447-Lymphatic Metastasis,
pubmed-meshheading:18234447-Middle Aged,
pubmed-meshheading:18234447-Neoplasm Recurrence, Local,
pubmed-meshheading:18234447-Prevalence,
pubmed-meshheading:18234447-Prognosis,
pubmed-meshheading:18234447-Radiotherapy,
pubmed-meshheading:18234447-Registries,
pubmed-meshheading:18234447-Risk Assessment,
pubmed-meshheading:18234447-Risk Factors,
pubmed-meshheading:18234447-Survival Analysis,
pubmed-meshheading:18234447-Survival Rate,
pubmed-meshheading:18234447-Texas,
pubmed-meshheading:18234447-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes.
|
pubmed:affiliation |
Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. tbuchhol@manderson.org
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|